Shanghai, China

Yansen Xiao

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yansen Xiao. Retrieved from https://idiyas.com/inventor/yansen-xiao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yansen Xiao: Innovator in Cancer Treatment

Introduction

Yansen Xiao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on addressing the challenges posed by cancer metastasis.

Latest Patents

Yansen Xiao holds a patent for "Methods for treating metastasis with cathepsin C inhibitors." This patent outlines methods for treating cancer metastasis using a pharmaceutical composition that includes an effective amount of a cathepsin C (CTSC) inhibitor. The CTSC inhibitor, in some embodiments, is a compound of Formula (I) or a pharmaceutically acceptable salt, such as brensocatib. The treatment methods described in the patent aim to inhibit, slow, or reverse the progression of metastasis. Additionally, the methods may involve reducing neutrophil infiltration and/or the formation of neutrophil extracellular traps (NETs).

Career Highlights

Yansen Xiao is affiliated with the Chinese Academy of Sciences, where he conducts his research and development activities. His work has garnered attention for its potential impact on cancer therapies and patient outcomes.

Collaborations

Yansen collaborates with esteemed colleagues, including Guohong Hu and Min Cong, who contribute to his research endeavors and help advance the field of cancer treatment.

Conclusion

Yansen Xiao's innovative approaches to treating cancer metastasis highlight his dedication to improving patient care through scientific research. His contributions to the field are significant and pave the way for future advancements in cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…